搜索医生

Ebbie A. Stewart, M.D.

  1. Gynecologist
  2. Reproductive Endocrinologist
预约门诊

出版物

  1. Stewart EA, Laughlin-Tommaso SK. Uterine Fibroids. N Engl J Med. 2024 Nov 7; 391 (18):1721-1733
    View PubMed
  2. Stewart EA, Lukes AS, Venturella R, Ferreira JA, Li Y, Hunsche E, Wagman RB, Al-Hendy A. A plain language summary describing changes in pain associated with uterine fibroids among women receiving relugolix combination therapy. Pain Manag. 2024 Oct 28; 1-8 [Epub ahead of print]
    View PubMed
  3. Ainsworth AJ, Sadecki E, Rauchfuss LMK, Betcher HK, Zhao Y, Smith CY, Stewart EA. Risks of Long-Term Psychiatric Disease in Women with a History of Primary Infertility: A Historical Cohort Study. Psychiatr Q. 2024 Oct 9 Epub 2024 Oct 09
    View PubMed
  4. Simon JA, Stewart EA, Jewell S, Li M, Snabes MC. Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy menstrual bleeding and uterine fibroids: a post hoc analysis of data from two clinical trials. F S Rep. 2024 Sep; 5 (3):285-295 Epub 2024 June 14
    View PubMed
  5. Stewart EA, Lukes AS, Venturella R, Li Y, Hunsche E, Wagman RB, Al-Hendy A. Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary. J Comp Eff Res. 2024 Aug; 13 (8):e230194 Epub 2024 June 27
    View PubMed
  6. Catherino WH, As-Sanie S, Cozzolino M, Marcellin L, Missmer SA, Stewart EA, van den Bosch T, Chapron C, Petraglia F. Society of Endometriosis and Uterine Disorders forum: adenomyosis today, Paris, France, December 12, 2023. F S Sci. 2024 Aug; 5 (3):265-271 Epub 2024 June 28
    View PubMed
  7. Makary MS, Zane K, Hwang GL, Kim CY, Ahmed O, Knavel Koepsel EM, Monroe EJ, Scheidt MJ, Smolock AR, Stewart EA, Wasnik AP, Pinchot JW, Expert Panel on Interventional Radiology. ACR Appropriateness Criteria(R) Management of Uterine Fibroids: 2023 Update. J Am Coll Radiol. 2024 Jun; 21 (6S):S203-S218
    View PubMed
  8. Orellana M, DSouza KN, Yap JQ, Sriganeshan A, Jones ME, Johnson C, Allyse M, Venable S, Stewart EA, Enders F, Balls-Berry JE. "In our community, we normalize pain": discussions around menstruation and uterine fibroids with Black women and Latinas. BMC Womens Health. 2024 Apr 12; 24 (1):233
    View PubMed
  9. Mannion S, Higgins A, Larson N, Stewart EA, Khan Z, Shenoy C, Nichols HB, Su HI, Partridge AH, Loprinzi CL, Couch F, Olson JE, Ruddy KJ. Prevalence and impact of fertility concerns in young women with breast cancer. Sci Rep. 2024 Feb 22; 14 (1):4418
    View PubMed
  10. Stewart EA, Al-Hendy A, Lukes AS, Madueke-Laveaux OS, Zhu E, Proehl S, Schulmann T, Marsh EE. Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study. Am J Obstet Gynecol. 2024 Feb; 230 (2):237.e1-237.e11 Epub 2023 Oct 18
    View PubMed
  11. Thao V, Moriarty JP, Stewart EA, Borah BJ. Cost-effectiveness of Myomectomy versus Hysterectomy in Women with Uterine Fibroids. J Minim Invasive Gynecol. 2023 Oct; 30 (10):813-819 Epub 2023 June 05
    View PubMed
  12. Anchan RM, Spies JB, Zhang S, Wojdyla D, Bortoletto P, Terry K, Disler E, Milne A, Gargiulo A, Petrozza J, Brook O, Srouji S, Morton CC, Greenberg J, Wegienka G, Stewart EA, Nicholson WK, Thomas L, Venable S, Laughlin-Tommaso S, Diamond MP, Maxwell GL, Marsh EE, Myers ER, Vines AI, Wise LA, Wallace K, Jacoby VL. Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids. Am J Obstet Gynecol. 2023 Sep; 229 (3):275.e1-275.e17 Epub 2023 May 26
    View PubMed
  13. Lee S, Stewart EA. New treatment options for nonsurgical management of uterine fibroids. Curr Opin Obstet Gynecol. 2023 Aug 1; 35 (4):288-293 Epub 2023 May 03
    View PubMed
  14. Al-Hendy A, Lukes AS, Venturella R, Villarroel C, McKain L, Li Y, Wagman RB, Stewart EA. A plain language summary of the long-term relugolix combination therapy study for uterine fibroids. J Comp Eff Res. 2023 Aug; 12 (8):e230069 Epub 2023 July 21
    View PubMed
  15. Hineman H, Middleton H, Stewart E. An Atypical Presentation of a Uterine Fibroid The Journal for Nurse Practitioners. 2023; 19(8).
  16. Miller CM, Melikian REM, Jones TL, Purdy MP, Khan Z, Bleess JL, Stewart EA, Coddington CC, Shenoy CC. Follicle Stimulating Hormone (FSH) as a Predictor of Decreased Oocyte Yield in Patients with Normal Anti-Mullerian Hormone (AMH) and Antral Follicle Count (AFC). J Reprod Infertil. 2023 Jul-Sep; 24 (3):181-187
    View PubMed
  17. Farland LV, Rice MS, Degnan WJ 3rd, Rexrode KM, Manson JE, Rimm EB, Rich-Edwards J, Stewart EA, Cohen Rassier SL, Robinson WR, Missmer SA. Hysterectomy With and Without Oophorectomy, Tubal Ligation, and Risk of Cardiovascular Disease in the Nurses' Health Study II. J Womens Health (Larchmt). 2023 Jul; 32 (7):747-756 Epub 2023 May 08
    View PubMed
  18. Neblett MF 2nd, Stewart EA. Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas. Obstet Gynecol. 2023 May 01; 141(5):901-910. Epub 2023 Apr 05.
    View PubMed
  19. Anchan RM, Wojdyla D, Bortoletto P, Terry K, Disler E, Milne A, Gargiulo A, Petrozza J, Brook O, Srouji S, Morton CC, Greenberg J, Wegienka G, Stewart EA, Nicholson WK, Thomas L, Venable S, Laughlin-Tommaso S, Diamond MP, Maxwell GL, Marsh EE, Myers ER, Vines AI, Wise LA, Wallace K, Jacoby VL, Spies JB. A Comparative Analysis of Health-Related Quality of Life 1 Year Following Myomectomy or Uterine Artery Embolization: Findings from the COMPARE-UF Registry. J Womens Health (Larchmt). 2023 Apr; 32 (4):423-433 Epub 2023 Jan 13
    View PubMed
  20. Rocca WA, Gazzuola Rocca L, Smith CY, Kapoor E, Faubion SS, Stewart EA. Frequency and type of premature or early menopause in a geographically defined American population. Maturitas. 2023 Apr; 170:22-30 Epub 2023 Feb 06
    View PubMed
  21. Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, Critchley HO, Li Y, McKain L, Arjona Ferreira JC, Langenberg AG, Wagman RB, Stewart EA. A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies. Pain Manag. 2023 Apr; 13 (4):205-211 Epub 2023 May 15
    View PubMed
  22. Stewart EA, Lukes AS, Venturella R, Li Y, Hunsche E, Wagman RB, Al-Hendy A. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials. Am J Obstet Gynecol. 2023 Mar; 228 (3):320.e1-320.e11 Epub 2022 Nov 09
    View PubMed
  23. Andersson JK, Mucelli RP, Epstein E, Stewart EA, Gemzell-Danielsson K. Vaginal bromocriptine for treatment of adenomyosis: impact on magnetic resonance imaging and transvaginal ultrasound. Obstetrical and Gynecological Survey. 2023; 78 (1):32-3
  24. Tang Y, Ponandai-Srinivasan S, Frisendahl C, Andersson JK, Pavone D, Stewart EA, Lalitkumar PGL, Korsching E, Bogavarappu NR, Gemzell-Danielsson K. Bromocriptine inhibits proliferation in the endometrium from women with adenomyosis. Front Endocrinol (Lausanne). 2023; 14:1026168 Epub 2023 Mar 09
    View PubMed
  25. Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, McKain L, Li Y, Wagman RB, Stewart EA. Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas. Obstet Gynecol. 2022 Dec 1; 140 (6):920-930 Epub 2022 Nov 02
    View PubMed
  26. Ainsworth AJ, Sadecki E, Zhao Y, Weaver AL, Stewart EA. Women With a History of Primary Infertility and Increased Rates of Bilateral Oophorectomy. Obstet Gynecol. 2022 Oct 1; 140 (4):643-653 Epub 2022 Sept 07
    View PubMed
  27. Donnez J, Taylor HS, Stewart EA, Bradley L, Marsh E, Archer D, Al-Hendy A, Petraglia F, Watts N, Gotteland JP, Bestel E, Terrill P, Loumaye E, Humberstone A, Garner E. Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials. Lancet. 2022 Sep 17; 400 (10356):896-907
    View PubMed
  28. Harvey RE, Laughlin-Tommaso SK, Stewart EA, Limberg JK, Curry TB, Joyner MJ, Barnes JN. The relationship between muscle sympathetic nerve activity and systemic hemodynamics is altered in women with uterine fibroids. Physiol Rep. 2022 Sep; 10 (18):e15445
    View PubMed
  29. Orellana M, Riggan KA, DSouza K, Stewart EA, Venable S, Balls-Berry JE, Allyse MA. Perceptions of Ethnoracial Factors in the Management and Treatment of Uterine Fibroids. J Racial Ethn Health Disparities. 2022 Aug; 9 (4):1184-1191 Epub 2021 May 19
    View PubMed
  30. Cohen Rassier SL, Louie MY, Hopkins MR, Stewart EA, Laughlin-Tommaso SK. Letter to the Editor re Shen et al. Menopause. 2022 Aug 1; 29 (8):999 Epub 2022 July 19
    View PubMed
  31. Stewart EA, Lukes AS, Venturella R, Arjona Ferreira JC, Li Y, Hunsche E, Wagman RB, Al-Hendy A. Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials. Obstet Gynecol. 2022 Jun 1; 139 (6):1070-1081 Epub 2022 May 02
    View PubMed
  32. Wise LA, Thomas L, Anderson S, Baird DD, Anchan RM, Terry KL, Marsh EE, Wegienka G, Nicholson WK, Wallace K, Bigelow R, Spies J, Maxwell GL, Jacoby V, Myers ER, Stewart EA. Route of myomectomy and fertility: a prospective cohort study. Fertil Steril. 2022 May; 117 (5):1083-1093 Epub 2022 Feb 23
    View PubMed
  33. Stewart EA, Archer DF, Owens CD, Barnhart KT, Bradley LD, Feinberg EC, Gillispie-Bell V, Imudia AN, Liu R, Kim JH, Al-Hendy A. Reduction of Heavy Menstrual Bleeding in Women Not Designated as Responders to Elagolix Plus Add Back Therapy for Uterine Fibroids. J Womens Health (Larchmt). 2022 May; 31 (5):698-705 Epub 2021 Sept 28
    View PubMed
  34. Erickson Z, Rocca WA, Smith CY, Gazzuola Rocca L, Stewart EA, Laughlin-Tommaso SK, Mielke MM. Time Trends in Unilateral and Bilateral Oophorectomy in a Geographically Defined American Population. Obstet Gynecol. 2022 May 1; 139 (5):724-734 Epub 2022 Apr 05
    View PubMed
  35. Laughlin-Tommaso SK, Gorny KR, Hesley GK, Vaughan LE, Woodrum DA, Lemens MA, Stewart EA. Uterine and Fibroid Imaging Analysis from the FIRSTT Study. J Womens Health (Larchmt). 2022 Apr; 31 (4):546-554 Epub 2021 July 08
    View PubMed
  36. Wallace K, Stewart EA, Wise LA, Nicholson WK, Parry JP, Zhang S, Laughlin-Tommaso S, Jacoby V, Anchan RM, Diamond MP, Venable S, Shiflett A, Wegienka GR, Maxwell GL, Wojdyla D, Myers ER, Marsh E. Anxiety, Depression, and Quality of Life After Procedural Intervention for Uterine Fibroids. J Womens Health (Larchmt). 2022 Mar; 31 (3):415-424 Epub 2021 June 08
    View PubMed
  37. Sadecki E, Weaver A, Zhao Y, Stewart EA, Ainsworth AJ. Fertility trends and comparisons in a historical cohort of US women with primary infertility. Reprod Health. 2022 Jan 18; 19 (1):13
    View PubMed
  38. Stewart EA, Nowak RA. Uterine Fibroids: Hiding in Plain Sight. Physiology (Bethesda). 2022 Jan 1; 37 (1):16-27
    View PubMed
  39. Shenoy CC, Khan Z, Coddington CC, Stewart EA, Morbeck DE. Symmetry at the 4-Cell Stage Is Associated with Embryo Aneuploidy. Reprod Sci. 2021 Dec; 28 (12):3473-3479 Epub 2021 Oct 18
    View PubMed
  40. Rocca WA, Mielke MM, Gazzuola Rocca L, Stewart EA. Premature or early bilateral oophorectomy: a 2021 update. Climacteric. 2021 Oct; 24 (5):466-473 Epub 2021 Mar 15
    View PubMed
  41. Muneyyirci-Delale O, Archer DF, Owens CD, Barnhart KT, Bradley LD, Feinberg E, Gillispie V, Hurtado S, Kim JH, Wang A, Wang H, Stewart EA. Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis. F S Rep. 2021 Sep; 2 (3):338-346 Epub 2021 May 26
    View PubMed
  42. Ruddy KJ, Schaid DJ, Batzler A, Cecchini RS, Partridge AH, Norman A, Fehrenbacher L, Stewart EA, Trabuco E, Ginsburg E, Couch FJ, Fasching PA, Vachon C, Ganz PA. Antimullerian Hormone as a Serum Biomarker for Risk of Chemotherapy-Induced Amenorrhea. J Natl Cancer Inst. 2021 Aug 2; 113 (8):1105-1108
    View PubMed
  43. Stewart EA, Adelman MR, Jacoby VL. Management of Symptomatic Uterine Leiomyomas (ACOG Practice Bulletin) Obstetrics and Gynecology. 2021; 137:e100.
  44. Starlinger J, Schrier VJMM, Smith CY, Song J, Stewart EA, Gazzuola Rocca L, Amadio PC, Rocca WA. Risk of de novo severe carpal tunnel syndrome after bilateral oophorectomy: a population-based cohort study. Menopause. 2021 May 24; 28 (9):1026-1036
    View PubMed
  45. Wegienka G, Stewart EA, Nicholson WK, Zhang S, Li F, Thomas L, Spies JB, Venable S, Laughlin-Tommaso S, Diamond MP, Anchan RM, Maxwell GL, Marsh EE, Myers ER, Vines AI, Wise LA, Wallace K, Jacoby VL. Black Women Are More Likely Than White Women to Schedule a Uterine-Sparing Treatment for Leiomyomas. J Womens Health (Larchmt). 2021 Mar; 30 (3):355-366 Epub 2021 Feb 01
    View PubMed
  46. Cope AG, Young RJ, Stewart EA. Non-extirpative Treatments for Uterine Myomas: Measuring Success. J Minim Invasive Gynecol. 2021 Mar; 28 (3):442-452.e4 Epub 2020 Aug 22
    View PubMed
  47. Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, Critchley HOD, Li Y, McKain L, Arjona Ferreira JC, Langenberg AGM, Wagman RB, Stewart EA. Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy. N Engl J Med. 2021 Feb 18; 384 (7):630-642
    View PubMed
  48. Leppert PC, Al-Hendy A, Baird DD, Bulun S, Catherino W, Dixon D, Ducharme M, Harmon QE, Jayes FL, Paul E, Perucho AM, Segars J, Simon C, Stewart EA, Teixeira J, Tinelli A, Tschumperlin D, Zota AR. Summary of the Proceedings of the Basic Science of Uterine Fibroids Meeting: New Developments February 28, 2020. F S Sci. 2021 Feb; 2 (1):88-100 Epub 2020 Nov 07
    View PubMed
  49. Stewart EA, Missmer SA, Rocca WA. Moving Beyond Reflexive and Prophylactic Gynecologic Surgery. Mayo Clin Proc. 2021 Feb; 96(2):291-294.
    View PubMed
  50. Stewart EA, Borah BJ. Uterine Fibroids and Hypertension: Steps Toward Understanding the Link. J Clin Endocrinol Metab 2021 Jan 23; 106 (2):e1039-e1041
    View PubMed
  51. Jones T, Purdy M, Stewart EA, Cutshall SM, Hathcock MA, Mahapatra S, Bauer BA, Ainsworth AJ. Lavender Aromatherapy to Reduce Anxiety During Intrauterine Insemination: A Randomized Controlled Trial. Glob Adv Health Med. 2021; 10:21649561211059074 Epub 2021 Nov 17
    View PubMed
  52. Riggan KA, Stewart EA, Balls-Berry JE, Venable S, Allyse MA. Patient Recommendations for Shared Decision-Making in Uterine Fibroid Treatment Decisions. J Patient Exp. 2021; 8:23743735211049655 Epub 2021 Oct 20
    View PubMed
  53. Al-Hendy A, Bradley L, Owens CD, Wang H, Barnhart KT, Feinberg E, Schlaff WD, Puscheck EE, Wang A, Gillispie V, Hurtado S, Muneyyirci-Delale O, Archer DF, Carr BR, Simon JA, Stewart EA. Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids. Am J Obstet Gynecol. 2021 Jan; 224 (1):72.e1-72.e50 Epub 2020 July 20
    View PubMed
  54. Andersson JK, Pozzi Mucelli R, Epstein E, Stewart EA, Gemzell-Danielsson K. Vaginal bromocriptine for treatment of adenomyosis: Impact on magnetic resonance imaging and transvaginal ultrasound. Eur J Obstet Gynecol Reprod Biol. 2020 Nov; 254:38-43 Epub 2020 Aug 24
    View PubMed
  55. Stewart EA. What do we do when new fibroids form following myomectomy? BJOG 2020 Oct; 127 (11):1429 Epub 2020 May 31
    View PubMed
  56. Halvorson LM, Giudice LC, Stewart EA. Eye to the Future in Adenomyosis Research. Semin Reprod Med. 2020 May; 38 (2-03):197-200 Epub 2020 Dec 11
    View PubMed
  57. Cope AG, Ainsworth AJ, Stewart EA. Current and Future Medical Therapies for Adenomyosis. Semin Reprod Med. 2020 May; 38 (2-03):151-156 Epub 2020 Oct 29
    View PubMed
  58. Laughlin-Tommaso SK, Lu D, Thomas L, Diamond MP, Wallace K, Wegienka G, Vines AI, Anchan RM, Wang T, Maxwell GL, Jacoby V, Marsh EE, Spies JB, Nicholson WK, Stewart EA, Myers ER. Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid Registry. Am J Obstet Gynecol. 2020 Apr; 222 (4):345.e1-345.e22 Epub 2019 Oct 31
    View PubMed
  59. Purdy MP, Ducharme M, Haak AJ, Ravix J, Tan Q, Sicard D, Prakash YS, Tschumperlin DJ, Stewart EA. YAP/TAZ are Activated by Mechanical and Hormonal Stimuli in Myometrium and Exhibit Increased Baseline Activation in Uterine Fibroids. Reprod Sci. 2020 Apr; 27 (4):1074-1085 Epub 2020 Feb 13
    View PubMed
  60. Wallace K, Zhang S, Thomas L, Stewart EA, Nicholson WK, Wegienka GR, Wise LA, Laughlin-Tommaso SK, Diamond MP, Marsh EE, Jacoby VL, Anchan RM, Venable S, Larry GM, Lytle B, Wang T, Myers ER. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids. Fertil Steril. 2020 Mar; 113 (3):618-626
    View PubMed
  61. Schlaff WD, Ackerman RT, Al-Hendy A, Archer DF, Barnhart KT, Bradley LD, Carr BR, Feinberg EC, Hurtado SM, Kim J, Liu R, Mabey RG Jr, Owens CD, Poindexter A, Puscheck EE, Rodriguez-Ginorio H, Simon JA, Soliman AM, Stewart EA, Watts NB, Muneyyirci-Delale O. Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids. N Engl J Med. 2020 Jan 23; 382 (4):328-340
    View PubMed
  62. Laughlin-Tommaso SK, Satish A, Khan Z, Smith CY, Rocca WA, Stewart EA. Long-term risk of de novo mental health conditions after hysterectomy with ovarian conservation: a cohort study. Menopause. 2020 Jan; 27 (1):33-42
    View PubMed
  63. Gazzuola Rocca L, Smith CY, Bobo WV, Grossardt BR, Stewart EA, Laughlin-Tommaso SK, Rocca WA. Mental health conditions diagnosed before bilateral oophorectomy: a population-based case-control study. Menopause. 2019 Dec; 26 (12):1395-1404
    View PubMed
  64. Andersson JK, Khan Z, Weaver AL, Vaughan LE, Gemzell-Danielsson K, Stewart EA. Vaginal bromocriptine improves pain, menstrual bleeding and quality of life in women with adenomyosis: A pilot study. Acta Obstet Gynecol Scand. 2019 Oct; 98 (10):1341-1350 Epub 2019 June 14
    View PubMed
  65. Ruddy KJ, Schaid DJ, Partridge AH, Larson NB, Batzler A, Haberle L, Dittrich R, Widschwendter P, Fink V, Bauer E, Schwitulla J, Rubner M, Ekici AB, Aivazova-Fuchs V, Stewart EA, Beckmann MW, Ginsburg E, Wang L, Weinshilboum RM, Couch FJ, Janni W, Rack B, Vachon C, Fasching PA. Genetic predictors of chemotherapy-related amenorrhea in women with breast cancer. Fertil Steril. 2019 Oct; 112 (4):731-739.e1 Epub 2019 July 29
    View PubMed
  66. Brito L, Stewart EA, Olivi SO, Martins WP, Farquhar C. Interventions for uterine fibroids: an overview of Cochrane Reviews Cochrane Database of Systematic Reviews. 2019; (9).
  67. Nicholson WK, Wegienka G, Zhang S, Wallace K, Stewart E, Laughlin-Tommaso S, Thomas L, Jacoby VL, Marsh EE, Wise L, Borah BJ, Spies J, Venable S, Anchan RM, Larry Maxwell G, Diamond M, Lytle B, Myers ER. Short-Term Health-Related Quality of Life After Hysterectomy Compared With Myomectomy for Symptomatic Leiomyomas. Obstet Gynecol. 2019 Aug; 134 (2):261-269
    View PubMed
  68. Stewart EA, Diamond MP, Williams ARW, Carr BR, Myers ER, Feldman RA, Elger W, Mattia-Goldberg C, Schwefel BM, Chwalisz K. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials. Hum Reprod. 2019 Apr 1; 34 (4):623-634
    View PubMed
  69. Cathcart-Rake EJ, Ruddy KJ, Gupta R, Kremers W, Gast K, Su HI, Partridge AH, Stewart EA, Liu H, He Y, Yang P. Amenorrhea after lung cancer treatment. Menopause. 2019 Mar; 26 (3):306-310
    View PubMed
  70. Laughlin-Tommaso S, Barnard EP, AbdElmagied AM, Vaughan LE, Weaver AL, Hesley GK, Woodrum DA, Jacoby VL, Kohi MP, Price TM, Nieves A, Miller MJ, Borah BJ, Moriarty JP, Gorny KR, Leppert PC, Severson AL, Lemens MA, Stewart EA. FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery. Am J Obstet Gynecol. 2019 Feb; 220(2):174.e1-174.e13. Epub 2018 Oct 26.
    View PubMed
  71. Multinu F, Casarin J, Tortorella L, Huang Y, Weaver A, Angioni S, Melis GB, Mariani A, Stewart EA, Laughlin-Tommaso SK. Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study. Am J Obstet Gynecol. 2019 Feb; 220 (2):179.e1-179.e10 Epub 2018 Nov 14
    View PubMed
  72. Laughlin-Tommaso SK, Fuchs EL, Wellons MF, Lewis CE, Calderon-Margalit R, Stewart EA, Schreiner PJ. Uterine Fibroids and the Risk of Cardiovascular Disease in the Coronary Artery Risk Development in Young Adult Women's Study. J Womens Health (Larchmt). 2019 Jan; 28 (1):46-52 Epub 2018 Nov 09
    View PubMed
  73. Edwards TL, Giri A, Hellwege JN, Hartmann KE, Stewart EA, Jeff JM, Bray MJ, Pendergrass SA, Torstenson ES, Keaton JM, Jones SH, Gogoi RP, Kuivaniemi H, Jackson KL, Kho AN, Kullo IJ, McCarty CA, Im HK, Pacheco JA, Pathak J, Williams MS, Tromp G, Kenny EE, Peissig PL, Denny JC, Roden DM, Velez Edwards DR. A Trans-Ethnic Genome-Wide Association Study of Uterine Fibroids. Front Genet. 2019; 10:511 Epub 2019 June 12
    View PubMed
  74. Diamond MP, Stewart EA, Williams ARW, Carr BR, Myers ER, Feldman RA, Elger W, Mattia-Goldberg C, Schwefel BM, Chwalisz K. A 12-month extension study to evaluate the safety and efficacy of asoprisnil in women with heavy menstrual bleeding and uterine fibroids. Hum Reprod Open. 2019; 2019 (4):hoz027 Epub 2019 Nov 04
    View PubMed
  75. Carr BR, Stewart EA, Archer DF, Al-Hendy A, Bradley L, Watts NB, Diamond MP, Gao J, Owens CD, Chwalisz K, Duan WR, Soliman AM, Dufek MB, Simon JA. Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial. Obstet Gynecol. 2018 Nov; 132 (5):1252-1264
    View PubMed
  76. Rocca WA, Gazzuola Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, Stewart EA, Mielke MM, Kantarci K, Miller VM. Personal, reproductive, and familial characteristics associated with bilateral oophorectomy in premenopausal women: A population-based case-control study. Maturitas. 2018 Nov; 117:64-77 Epub 2018 Sept 14
    View PubMed
  77. Rocca WA, Gazzuola Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, Kirkland JL, LeBrasseur NK, Schafer MJ, Mielke MM, Kantarci K, Stewart EA, Miller VM. Loss of Ovarian Hormones and Accelerated Somatic and Mental Aging. Physiology (Bethesda). 2018 Nov 1; 33 (6):374-383
    View PubMed
  78. Marsh EE, Al-Hendy A, Kappus D, Galitsky A, Stewart EA, Kerolous M. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women. J Womens Health (Larchmt). 2018 Nov; 27 (11):1359-1367 Epub 2018 Sept 19
    View PubMed
  79. Laughlin-Tommaso SK, Stewart EA. Moving Toward Individualized Medicine for Uterine Leiomyomas. Obstet Gynecol. 2018 Oct; 132 (4):961-971
    View PubMed
  80. Rocca WA, Gazzuola Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, Kirkland JL, LeBrasseur NK, Mielke MM, Kantarci K, Stewart EA, Miller VM. Ovarian Hormones and Somatic and Mental Aging Physiology. 2018.
  81. Stewart EA, Lytle BL, Thomas L, Wegienka GR, Jacoby V, Diamond MP, Nicholson WK, Anchan RM, Venable S, Wallace K, Marsh EE, Maxwell GL, Borah BJ, Catherino WH, Myers ER. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design. Am J Obstet Gynecol. 2018 Jul; 219 (1):95.e1-95.e10 Epub 2018 May 08
    View PubMed
  82. Jondal DE, Wang J, Chen J, Gorny KR, Felmlee J, Hesly G, Laughlin-Tommaso S, Stewart EA, Ehman R, Woodrum DA. Uterine fibroids: correlations between MRI appearance and stiffness via magnetic resonance elastography. Abdom Radiol (NY). 2018 Jun; 43 (6):1456-1463
    View PubMed
  83. Ravix JL, Purdy MP, Prakash YS, Stewart EA. Regulation of intracellular calcium in uterine leiomyomas FASEB. 2018.
  84. Laughlin-Tommaso SK, Khan Z, Weaver AL, Smith CY, Rocca WA, Stewart EA. Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study. Menopause. 2018 May; 25(5):483-492.
    View PubMed
  85. Hayden MA, Ordulu Z, Gallagher CS, Quade BJ, Anchan RM, Middleton NR, Srouji SS, Stewart EA, Morton CC. Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata. Cancer Genet. 2018 Apr; 222-223:1-8 Epub 2018 Feb 19
    View PubMed
  86. Rocca WA, Gazzuola Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, Stewart EA, Mielke MM, Kantarci K, Miller VM. Cohort profile: the Mayo Clinic Cohort Study of Oophorectomy and Aging-2 (MOA-2) in Olmsted County, Minnesota (USA). BMJ Open. 2017 Nov 20; 7 (11):e018861
    View PubMed
  87. Hellwege JN, Jeff JM, Wise LA, Gallagher CS, Wellons M, Hartmann KE, Jones SF, Torstenson ES, Dickinson S, Ruiz-Narvaez EA, Rohland N, Allen A, Reich D, Tandon A, Pasaniuc B, Mancuso N, Im HK, Hinds DA, Palmer JR, Rosenberg L, Denny JC, Roden DM, Stewart EA, Morton CC, Kenny EE, Edwards TL, Velez Edwards DR. Erratum to: A multi-stage genome-wide association study of uterine fibroids in African Americans. Hum Genet. 2017 Nov; 136 (11-12):1497-1498
    View PubMed
  88. Al-Hendy A, Myers ER, Stewart E. Uterine Fibroids: Burden and Unmet Medical Need. Semin Reprod Med. 2017 Nov; 35 (6):473-480 Epub 2017 Nov 03
    View PubMed
  89. Borah BJ, Yao X, Laughlin-Tommaso SK, Heien HC, Stewart EA. Comparative Effectiveness of Uterine Leiomyoma Procedures Using a Large Insurance Claims Database. Obstet Gynecol. 2017 Nov; 130 (5):1047-1056
    View PubMed
  90. Laughlin-Tommaso SK, Hesley GK, Hopkins MR, Brandt KR, Zhu Y, Stewart EA. Clinical limitations of the International Federation of Gynecology and Obstetrics (FIGO) classification of uterine fibroids. Int J Gynaecol Obstet. 2017 Nov; 139 (2):143-148 Epub 2017 Aug 14
    View PubMed
  91. Hellwege JN, Jeff JM, Wise LA, Gallagher CS, Wellons M, Hartmann KE, Jones SF, Torstenson ES, Dickinson S, Ruiz-Narvaez EA, Rohland N, Allen A, Reich D, Tandon A, Pasaniuc B, Mancuso N, Im HK, Hinds DA, Palmer JR, Rosenberg L, Denny JC, Roden DM, Stewart EA, Morton CC, Kenny EE, Edwards TL, Velez Edwards DR. A multi-stage genome-wide association study of uterine fibroids in African Americans. Hum Genet. 2017 Oct; 136 (10):1363-1373 Epub 2017 Aug 23
    View PubMed
  92. Rocca WA, Gazzuola Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, Kirkland JL, Stewart EA, Miller VM. Bilateral Oophorectomy and Accelerated Aging: Cause or Effect? J Gerontol A Biol Sci Med Sci. 2017 Sep 1; 72 (9):1213-1217
    View PubMed
  93. Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017 Sep; 124 (10):1501-1512 Epub 2017 May 13
    View PubMed
  94. Archer DF, Stewart EA, Jain RI, Feldman RA, Lukes AS, North JD, Soliman AM, Gao J, Ng JW, Chwalisz K. Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study. Fertil Steril. 2017 Jul; 108 (1):152-160.e4 Epub 2017 June 01
    View PubMed
  95. Bortoletto P, Lindsey JL, Yuan L, Quade BJ, Gargiulo AR, Morton CC, Stewart EA, Anchan RM. Hereditary leiomyomatosis and renal cell cancer: Cutaneous lesions & atypical fibroids. Case Rep Womens Health. 2017 Jul; 15:31-34 Epub 2017 June 23
    View PubMed
  96. Rocca WA, Gazzuola L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, Stewart EA, Miller VM. Cohort Profile: The Mayo Clinic Cohort Study of Oophorectomy. Int J Epidemiol. 2017.
  97. Gazzuola Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, Stewart EA, Rocca WA. Adverse childhood or adult experiences and risk of bilateral oophorectomy: a population-based case-control study. BMJ Open. 2017 Jun 7; 7 (5):e016045 Epub 2017 June 07
    View PubMed
  98. Barnard EP, AbdElmagied AM, Vaughan LE, Weaver AL, Laughlin-Tommaso SK, Hesley GK, Woodrum DA, Jacoby VL, Kohi MP, Price TM, Nieves A, Miller MJ, Borah BJ, Gorny KR, Leppert PC, Peterson LG, Stewart EA. Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis. Am J Obstet Gynecol. 2017 May; 216 (5):500.e1-500.e11 Epub 2017 Jan 05
    View PubMed
  99. Yao X, Stewart EA, Laughlin-Tommaso SK, Heien HC, Borah BJ. Medical therapies for heavy menstrual bleeding in women with uterine fibroids: a retrospective analysis of a large commercially insured population in the USA. BJOG. 2017 Jan; 124 (2):322-330 Epub 2016 Oct 21
    View PubMed
  100. Richards EG, Richards MS, Stewart EA, Laughlin-Tommaso SK. Ultrasound-Diagnosed Uterine Fibroids Are Not Associated with Creativity Scores by Standardized Testing. Explore (NY). 2016 Nov - Dec; 12: (6)440-442.
    View PubMed
  101. Rocca WA, Gazzuola-Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, Kirkland JL, Stewart EA, Miller VM. Accelerated Accumulation of Multimorbidity After Bilateral Oophorectomy: A Population-Based Cohort Study. Mayo Clin Proc. 2016 Nov; 91 (11):1577-1589 Epub 2016 Sept 29
    View PubMed
  102. AbdElmagied AM, Vaughan LE, Weaver AL, Laughlin-Tommaso SK, Hesley GK, Woodrum DA, Jacoby VL, Kohi MP, Price TM, Nieves A, Miller MJ, Borah BJ, Gorny KR, Leppert PC, Lemens MA, Stewart EA. Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trial. Am J Obstet Gynecol. 2016 Sep; 215 (3):338.e1-338.e18 Epub 2016 Apr 09
    View PubMed
  103. Stewart EA, Laughlin-Tommaso SK, Catherino WH, Lalitkumar S, Gupta D, Vollenhoven B. Uterine fibroids. Nat Rev Dis Primers. 2016 Jun 23; 2:16043 Epub 2016 June 23
    View PubMed
  104. Laughlin-Tommaso SK, Khan Z, Weaver AL, Schleck CD, Rocca WA, Stewart EA. Cardiovascular risk factors and diseases in women undergoing hysterectomy with ovarian conservation. Menopause. 2016 Feb; 23 (2):121-8
    View PubMed
  105. Borah BJ, Laughlin-Tommaso SK, Myers ER, Yao X, Stewart EA. Association Between Patient Characteristics and Treatment Procedure Among Patients With Uterine Leiomyomas. Obstet Gynecol. 2016 Jan; 127 (1):67-77
    View PubMed
  106. Khan Z, Laughlin-Tommaso SK, Weaver AL, Schleck CD, Rocca WA, Stewart EA. Long-Term Abdominopelvic Surgical Morbidity After Abdominal Vs. Minimally Invasive Hysterectomy With Ovarian Conservation: A Population-Based Cohort Study. J Minim Invasive Gynecol. 2015 Nov-Dec; 22 (6S):S65 Epub 2015 Oct 15
    View PubMed
  107. Laughlin-Tommaso SK, Borah BJ, Stewart EA. Effect of menses on standardized assessment of sexual dysfunction among women with uterine fibroids: a cohort study. Fertil Steril. 2015 Aug; 104 (2):435-9 Epub 2015 May 16
    View PubMed
  108. Borowski KS, Brost BC, Stewart EA, Hay EJ, Coddington CC 3rd. Preconception risk stratification before fertility care. Fertil Steril. 2015 Jul; 104 (1):28-31 Epub 2015 Apr 30
    View PubMed
  109. Leonard PH, Hokenstad AN, Khan Z, Jensen JR, Stewart EA, Coddington CC. Progesterone support for frozen embryo transfer: intramuscular versus vaginal suppository demonstrates no difference in a cohort. J Reprod Med. 2015 Mar-Apr; 60(3-4):103-8.
    View PubMed
  110. Asante A, Omurtag K, Stewart EA, Coddington CC. Screening for insulin resistance in polycystic ovary syndrome: Views of physician members of the American Society for Reproductive Medicine Journal of Reproductive Medicine. 2015; 60: (5)371-7.
    View PubMed
  111. Asante A, Verma U, Coddington CC, Stewart EA. Single-dose intramuscular methotrexate treatment of cervical ectopic pregnancy a case report. J Reprod Med. 2015 Jan-feb; 60(1-2):78-82.
    View PubMed
  112. Stewart EA. Uterine fibroids. N Engl J Med. 2015; 372(17):1646-55.
    View PubMed
  113. Gorny KR, Borah BJ, Brown DL, Woodrum DA, Stewart EA, Hesley GK. Incidence of additional treatments in women treated with MR-guided focused US for symptomatic uterine fibroids: review of 138 patients with an average follow-up of 2.8 years. J Vasc Interv Radiol. 2014 Oct; 25(10):1506-12. Epub 2014 Jul 03.
    View PubMed
  114. Cain-Nielsen AH, Moriarty JP, Stewart EA, Borah BJ. Cost-effectiveness of uterine-preserving procedures for the treatment of uterine fibroid symptoms in the USA. J Comp Eff Res. 2014 Sep; 3 (5):503-14 Epub 2014 May 30
    View PubMed
  115. Hodge JC, Pearce KE, Clayton AC, Taran FA, Stewart EA. Uterine cellular leiomyomata with chromosome 1p deletions represent a distinct entity. Am J Obstet Gynecol. 2014 Jun; 210 (6):572.e1-7 Epub 2014 Jan 08
    View PubMed
  116. Laughlin-Tommaso SK, Stewart EA, Grossardt BR, Rocca LG, Rocca WA. Incidence, time trends, laterality, indications, and pathological findings of unilateral oophorectomy before menopause. Menopause. 2014 May; 21 (5):442-9
    View PubMed
  117. Eltoukhi HM, Modi MN, Weston M, Armstrong AY, Stewart EA. The health disparities of uterine fibroid tumors for African American women: a public health issue. Am J Obstet Gynecol. 2014 Mar; 210 (3):194-9 Epub 2013 Aug 11
    View PubMed
  118. Khan Z, Gada RP, Tabbaa ZM, Laughlin-Tommaso SK, Jensen JR, Coddington CC 3rd, Stewart EA. Unilateral oophorectomy results in compensatory follicular recruitment in the remaining ovary at time of ovarian stimulation for in vitro fertilization. Fertil Steril. 2014 Mar; 101: (3)722-7.
    View PubMed
  119. Brucker SY, Huebner M, Wallwiener M, Stewart EA, Ebersoll S, Schoenfisch B, Taran FA. Clinical characteristics indicating adenomyosis coexisting with leiomyomas: a retrospective, questionnaire-based study. Fertil Steril. 2014 Jan; 101(1):237-241.e1. Epub 2013 Nov 1
    View PubMed
  120. Borah BJ, Carls GS, Moore BJ, Gibson TB, Moriarty JP, Stewart EA. Cost comparison between uterine-sparing fibroid treatments one year following treatment. J Ther Ultrasound. 2014; 2:7 Epub 2014 Mar 31
    View PubMed
  121. Puri K, Famuyide AO, Erwin PJ, Stewart EA, Laughlin-Tommaso SK. Submucosal fibroids and the relation to heavy menstrual bleeding and anemia. Am J Obstet Gynecol. 2014 Jan; 210 (1):38.e1-7 Epub 2013 Sept 28
    View PubMed
  122. Asante A, Coddington CC, Schenck L, Stewart EA. Thin endometrial stripe does not affect likelihood of achieving pregnancy in clomiphene citrate/intrauterine insemination cycles. Fertil Steril. 2013 Dec; 100: (6)1610-4.e1.
    View PubMed
  123. Stewart EA, Nicholson WK, Bradley L, Borah BJ. The burden of uterine fibroids for African-American women: results of a national survey. J Womens Health (Larchmt). 2013 Oct; 22 (10):807-16 Epub 2013 Sept 14
    View PubMed
  124. Borah BJ, Nicholson WK, Bradley L, Stewart EA. The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol. 2013 Oct; 209 (4):319.e1-319.e20 Epub 2013 July 24
    View PubMed
  125. Taran FA, Stewart EA, Brucker S. Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy. Geburtshilfe Frauenheilkd. 2013 Sep; 73 (9):924-931
    View PubMed
  126. Asante A, Leonard PH, Weaver AL, Goode EL, Jensen JR, Stewart EA, Coddington CC. Fertility drug use and the risk of ovarian tumors in infertile women: a case-control study. Fertil Steril. 2013 Jun; 99 (7):2031-6 Epub 2013 Apr 01
    View PubMed
  127. Machtinger R, Fennessy FM, Stewart EA, Missmer SA, Correia KF, Tempany CM. MR-guided focused ultrasound (MRgFUS) is effective for the distinct pattern of uterine fibroids seen in African-American women: data from phase III/IV, non-randomized, multicenter clinical trials. J Ther Ultrasound. 2013; 1:23 Epub 2013 Dec 02
    View PubMed
  128. Brown DL, Hesley GK, Gorny KR, Stewart EA. Safety of mr-guided focused ultrasound treatment of pedunculated subserosal uterine leiomyomas Journal of Therapeutic Ultrasound. 2013; 1: (1)19.
  129. Gorny KR, Borah BJ, Weaver AL, Brown D, Woodrum DA, Stewart EA, Hesley GK. Clinical predictors of successful magnetic resonance-guided focused ultrasound (MRgFUS) for uterine leiomyoma. J Ther Ultrasound. 2013; 1:15 Epub 2013 Sept 02
    View PubMed
  130. Eggert SL, Huyck KL, Somasundaram P, Kavalla R, Stewart EA, Lu AT, Painter JN, Montgomery GW, Medland SE, Nyholt DR, Treloar SA, Zondervan KT, Heath AC, Madden PA, Rose L, Buring JE, Ridker PM, Chasman DI, Martin NG, Cantor RM, Morton CC. Genome-wide linkage and association analyses implicate FASN in predisposition to Uterine Leiomyomata. Am J Hum Genet. 2012 Oct 5; 91(4):621-8.
    View PubMed
  131. Hodge JC, Kim TM, Dreyfuss JM, Somasundaram P, Christacos NC, Rousselle M, Quade BJ, Park PJ, Stewart EA, Morton CC. Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity. Hum Mol Genet. 2012 May 15; 21(10):2312-29. Epub 2012 Feb 17.
    View PubMed
  132. Stewart EA, Shuster LT, Rocca WA. Reassessing hysterectomy. Minn Med. 2012 Mar; 95 (3):36-9
    View PubMed
  133. Rocca WA, Grossardt BR, Shuster LT, Stewart EA. Hysterectomy, oophorectomy, estrogen, and the risk of dementia. Neurodegener Dis. 2012; 10 (1-4):175-8 Epub 2012 Jan 21
    View PubMed
  134. Wechter ME, Stewart EA, Myers ER, Kho RM, Wu JM. Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trends. Am J Obstet Gynecol. 2011 Nov; 205 (5):492.e1-5 Epub 2011 July 20
    View PubMed
  135. Bouwsma EV, Hesley GK, Woodrum DA, Weaver AL, Leppert PC, Peterson LG, Stewart EA. Comparing focused ultrasound and uterine artery embolization for uterine fibroids-rationale and design of the Fibroid Interventions: reducing symptoms today and tomorrow (FIRSTT) trial. Fertil Steril. 2011 Sep; 96 (3):704-10 Epub 2011 July 27
    View PubMed
  136. Bouwsma EV, Gorny KR, Hesley GK, Jensen JR, Peterson LG, Stewart EA. Magnetic resonance-guided focused ultrasound surgery for leiomyoma-associated infertility. Fertil Steril. 2011 Jul; 96 (1):e9-e12 Epub 2011 May 13
    View PubMed
  137. Gorny KR, Woodrum DA, Brown DL, Henrichsen TL, Weaver AL, Amrami KK, Hangiandreou NJ, Edmonson HA, Bouwsma EV, Stewart EA, Gostout BS, Ehman DA, Hesley GK. Magnetic resonance-guided focused ultrasound of uterine leiomyomas: review of a 12-month outcome of 130 clinical patients. J Vasc Interv Radiol. 2011 Jun; 22 (6):857-64 Epub 2011 Apr 08
    View PubMed
  138. Laughlin SK, Stewart EA. Uterine leiomyomas: individualizing the approach to a heterogeneous condition. Obstet Gynecol. 2011 Feb; 117 (2 Pt 1):396-403
    View PubMed
  139. Stewart EA, Taran FA, Chen J, Gostout BS, Woodrum DA, Felmlee JP, Ehman RL. Magnetic resonance elastography of uterine leiomyomas: a feasibility study. Fertil Steril. 2011 Jan; 95 (1):281-4 Epub 2010 July 15
    View PubMed
  140. Taran FA, Weaver AL, Coddington CC, Stewart EA. Understanding adenomyosis: a case control study. Fertil Steril. 2010 Sep; 94 (4):1223-1228 Epub 2009 July 30
    View PubMed
  141. Taran FA, Brown HL, Stewart EA. Racial diversity in uterine leiomyoma clinical studies. Fertil Steril. 2010 Sep; 94 (4):1500-1503 Epub 2009 Dec 06
    View PubMed
  142. Taran FA, Weaver AL, Gostout BS, Stewart EA. Understanding cellular leiomyomas: a case-control study. Am J Obstet Gynecol. 2010 Aug; 203 (2):109.e1-6 Epub 2010 May 10
    View PubMed
  143. Taran FA, Hesley GK, Gorny KR, Stewart EA. What factors currently limit magnetic resonance-guided focused ultrasound of leiomyomas? A survey conducted at the first international symposium devoted to clinical magnetic resonance-guided focused ultrasound. Fertil Steril. 2010 Jun; 94 (1):331-4 Epub 2009 Apr 21
    View PubMed
  144. Taran FA, Weaver AL, Coddington CC, Stewart EA. Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study. Hum Reprod. 2010 May; 25 (5):1177-82 Epub 2010 Feb 22
    View PubMed
  145. Al Hilli MM, Stewart EA. Magnetic resonance-guided focused ultrasound surgery. Semin Reprod Med. 2010 May; 28(3):242-9. Epub 2010 Apr 22.
    View PubMed
  146. Rabinovici J, David M, Fukunishi H, Morita Y, Gostout BS, Stewart EA, MRgFUS Study. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril. 2010 Jan; 93(1):199-209. Epub 2008 Nov 14.
    View PubMed
  147. Taran FA, Tempany CM, Regan L, Inbar Y, Revel A, Stewart EA, MRgFUS Group. Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas. Ultrasound Obstet Gynecol. 2009 Nov; 34: (5)572-8.
    View PubMed
  148. Hodge JC, Park PJ, Dreyfuss JM, Assil-Kishawi I, Somasundaram P, Semere LG, Quade BJ, Lynch AM, Stewart EA, Morton CC. Identifying the molecular signature of the interstitial deletion 7q subgroup of uterine leiomyomata using a paired analysis. Genes Chromosomes Cancer. 2009 Oct; 48(10):865-85.
    View PubMed
  149. Betjes HE, Hanstede MM, Emanuel MH, Stewart EA. Hysteroscopic myomectomy and case volume hysteroscopic myomectomy performed by high- and low-volume surgeons. J Reprod Med. 2009 Jul; 54(7):425-8.
    View PubMed
  150. Hanstede MM, Wise LA, Stewart EA, Feldman S. The relation of annual surgeon case volume to clinical outcomes and resource utilization in abdominal hysterectomy. J Reprod Med. 2009 Apr; 54(4):193-202.
    View PubMed
  151. Hodge JC, T Cuenco K, Huyck KL, Somasundaram P, Panhuysen CI, Stewart EA, Morton CC. Uterine leiomyomata and decreased height: a common HMGA2 predisposition allele. Hum Genet. 2009 Apr; 125(3):257-63. Epub 2009 Jan 09.
    View PubMed
  152. Pilatou MC, Stewart EA, Maier SE, Fennessy FM, Hynynen K, Tempany CM, McDannold N. MRI-based thermal dosimetry and diffusion-weighted imaging of MRI-guided focused ultrasound thermal ablation of uterine fibroids. J Magn Reson Imaging. 2009 Feb; 29(2):404-11.
    View PubMed
  153. Lee DW, Gibson TB, Carls GS, Ozminkowski RJ, Wang S, Stewart EA. Uterine fibroid treatment patterns in a population of insured women. Fertil Steril. 2009 Feb; 91(2):566-74. Epub 2008 Mar 04.
    View PubMed
  154. O'Sullivan AK, Thompson D, Chu P, Lee DW, Stewart EA, Weinstein MC. Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids. Int J Technol Assess Health Care. 2009 Jan; 25(1):14-25.
    View PubMed
  155. Armstrong AY, Alvero RJ, Dunlow S, Nace MC, Baker V, Stewart EA. Balancing the professional and personal. Fertil Steril. 2009 Jan; 91(1):18-21. Epub 2008 Jan 11.
    View PubMed
  156. Stewart EA, Zhang J, Cuenco KT. Reply to Letter to Editor E08-5108A. Am J Obstet Gynecol. 2008 Dec 1; 199 (6):e12-e13
    View PubMed
  157. Hanstede MM, Emanuel MH, Stewart EA. Outcomes for abdominal myomectomies among high-volume surgeons. J Reprod Med. 2008 Dec; 53(12):941-6.
    View PubMed
  158. Lenard ZM, McDannold NJ, Fennessy FM, Stewart EA, Jolesz FA, Hynynen K, Tempany CM. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery--imaging predictors of success. Radiology. 2008 Oct; 249(1):187-94. Epub 2008 Aug 11.
    View PubMed
  159. Carls GS, Lee DW, Ozminkowski RJ, Wang S, Gibson TB, Stewart E. What are the total costs of surgical treatment for uterine fibroids? J Womens Health (Larchmt). 2008 Sep; 17(7):1119-32.
    View PubMed
  160. Samuel A, Fennessy FM, Tempany CM, Stewart EA. Avoiding treatment of leiomyosarcomas: the role of magnetic resonance in focused ultrasound surgery. Fertil Steril. 2008 Sep; 90(3):850.e9-12. Epub 2007 Nov 26.
    View PubMed
  161. ACOG Committee on Practice Bulletins, Stewart EA. Alternatives to hysterectomy in the management of leiomyomas. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetricians-Gynecologists. 2008 Aug(96).
  162. Hodge JC, Quade BJ, Rubin MA, Stewart EA, Dal Cin P, Morton CC. Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids. Am J Pathol. 2008 May; 172(5):1403-10. Epub 2008 Apr 10.
    View PubMed
  163. Hudson SB, Stewart EA. Magnetic resonance-guided focused ultrasound surgery. Clin Obstet Gynecol. 2008 Mar; 51(1):159-66.
    View PubMed
  164. Huyck KL, Panhuysen CI, Cuenco KT, Zhang J, Goldhammer H, Jones ES, Somasundaram P, Lynch AM, Harlow BL, Lee H, Stewart EA, Morton CC. The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters. Am J Obstet Gynecol. 2008 Feb; 198(2):168.e1-9.
    View PubMed
  165. Wise LA, Palmer JR, Cozier YC, Hunt MO, Stewart EA, Rosenberg L. Perceived racial discrimination and risk of uterine leiomyomata. Epidemiology. 2007 Nov; 18(6):747-57.
    View PubMed
  166. Hanstede MM, Tempany CM, Stewart EA. Focused ultrasound surgery of intramural leiomyomas may facilitate fertility: a case report. Fertil Steril. 2007 Aug; 88(2):497.e5-7.
    View PubMed
  167. Stewart EA, Gostout B, Rabinovici J, Kim HS, Regan L, Tempany CM. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol. 2007 Aug; 110(2 Pt 1):279-87.
    View PubMed
  168. Fennessy FM, Tempany CM, McDannold NJ, So MJ, Hesley G, Gostout B, Kim HS, Holland GA, Sarti DA, Hynynen K, Jolesz FA, Stewart EA. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery--results of different treatment protocols. Radiology. 2007 Jun; 243(3):885-93. Epub 2007 Apr 19.
    View PubMed
  169. Wise LA, Palmer JR, Stewart EA, Rosenberg L. Polycystic ovary syndrome and risk of uterine leiomyomata. Fertil Steril. 2007 May; 87(5):1108-15. Epub 2007 Jan 22.
    View PubMed
  170. Lee DW, Ozminkowski RJ, Carls GS, Wang S, Gibson TB, Stewart EA. The direct and indirect cost burden of clinically significant and symptomatic uterine fibroids. J Occup Environ Med. 2007 May; 49(5):493-506.
    View PubMed
  171. Spies JB, Rundback JH, Ascher S, Bradley L, Goodwin SC, Hovsepian DM, Myers ER, Pelage JP, Pron G, Siskin GP, Stewart EA, Worthington-Kirsch R, Hume KM, Strain C, Gomolka B, SIR Foundation. Development of a research agenda for uterine artery embolization: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol. 2006 Dec; 17(12):1871-9.
    View PubMed
  172. So MJ, Fennessy FM, Zou KH, McDannold N, Hynynen K, Jolesz FA, Stewart EA, Rybicki FJ, Tempany CM. Does the phase of menstrual cycle affect MR-guided focused ultrasound surgery of uterine leiomyomas? Eur J Radiol. 2006 Aug; 59(2):203-7.
    View PubMed
  173. Rabinovici J, Stewart EA. New interventional techniques for adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006 Aug; 20:617-36.
  174. McDannold N, Tempany CM, Fennessy FM, So MJ, Rybicki FJ, Stewart EA, Jolesz FA, Hynynen K. Uterine leiomyomas: MR imaging-based thermometry and thermal dosimetry during focused ultrasound thermal ablation. Radiology. 2006 Jul; 240(1):263-72.
    View PubMed
  175. Stewart EA, Morton CC. The genetics of uterine leiomyomata: what clinicians need to know. Obstet Gynecol. 2006 Apr; 107(4):917-21.
    View PubMed
  176. Stewart EA, Rabinovici J, Tempany CM, Inbar Y, Regan L, Gostout B, Hesley G, Kim HS, Hengst S, Gedroyc WM. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril. 2006 Jan; 85(1):22-9.
    View PubMed
  177. Goodwin SC, Bradley LD, Lipman JC, Stewart EA, Nosher JL, Sterling KM, Barth MH, Siskin GP, Shlansky-Goldberg RD, UAE versus Myomectomy Study Group. Uterine artery embolization versus myomectomy: a multicenter comparative study. Fertil Steril. 2006 Jan; 85(1):14-21.
    View PubMed
  178. Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science. 2005 Jun 10; 308(5728):1589-92.
  179. Wise LA, Palmer JR, Spiegelman D, Harlow BL, Stewart EA, Adams-Campbell LL, Rosenberg L. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology. 2005 May; 16(3):346-54.
    View PubMed
  180. Wise LA, Palmer JR, Stewart EA, Rosenberg L. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol. 2005 Mar; 105(3):563-8.
    View PubMed
  181. Hindley J, Gedroyc WM, Regan L, Stewart E, Tempany C, Hynyen K, McDannold N, Inbar Y, Itzchak Y, Rabinovici J, Kim HS, Geschwind JF, Hesley G, Gostout B, Ehrenstein T, Hengst S, Sklair-Levy M, Shushan A, Jolesz F. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol. 2004 Dec; 183(6):1713-9.
    View PubMed
  182. Gross KL, Panhuysen CI, Kleinman MS, Goldhammer H, Jones ES, Nassery N, Stewart EA, Morton CC. Involvement of fumarate hydratase in nonsyndromic uterine leiomyomas: genetic linkage analysis and FISH studies. Genes Chromosomes Cancer. 2004 Nov; 41(3):183-90.
    View PubMed
  183. Wise LA, Palmer JR, Harlow BL, Spiegelman D, Stewart EA, Adams-Campbell LL, Rosenberg L. Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the black women's health study. Hum Reprod. 2004 Aug; 19(8):1746-54.
  184. Wise LA, Palmer JR, Harlow BL, Spiegelman D, Stewart EA, Adams-Campbell LL, Rosenberg L. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol. 2004 Jan 15; 159(2):113-23.
    View PubMed
  185. Stewart EA, Gedroyc WM, Tempany CM, Quade BJ, Inbar Y, Ehrenstein T, Shushan A, Hindley JT, Goldin RD, David M, Sklair M, Rabinovici J. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol. 2003 Jul; 189(1):48-54.
    View PubMed
  186. Chavez NF, Zweizig SL, Stewart EA. Neuropathic uterine pain after hysterectomy. A case report. J Reprod Med. 2003 Jun; 48(6):466-8.
    View PubMed
  187. Tempany CM, Stewart EA, McDannold N, Quade BJ, Jolesz FA, Hynynen K. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology. 2003 Mar; 226(3):897-905.
    View PubMed
  188. Propst AM, Quade BJ, Nowak RA, Stewart EA. Granulocyte macrophage colony-stimulating factor in adenomyosis and autologous endometrium. J Soc Gynecol Investig. 2002 Mar-Apr; 9(2):93-7.
    View PubMed
  189. Stewart EA, Faur AV, Wise LA, Reilly RJ, Harlow BL. Predictors of subsequent surgery for uterine leiomyomata after abdominal myomectomy. Obstet Gynecol. 2002 Mar; 99(3):426-32.
    View PubMed
  190. Chavez NF, Garner EO, Khan W, Quade BJ, Sharif NA, Syed F, Stewart EA. Does the introduction of new technology change population demographics? Minimally invasive technologies and endometrial polyps. Gynecol Obstet Invest. 2002; 54(4):217-20.
    View PubMed
  191. Stewart EA. Non-surgical treatment of uterine fibroids. Infert Reprod Med Clin N Am. 2002; 393-405.
  192. Stewart EA. Gonadotropins and the uterus: is there a gonad-independent pathway? J Soc Gynecol Investig. 2001 Nov-Dec; 8(6):319-26.
    View PubMed
  193. Propst AM, Quade BJ, Gargiulo AR, Nowak RA, Stewart EA. Adenomyosis demonstrates increased expression of the basic fibroblast growth factor receptor/ligand system compared with autologous endometrium. Menopause. 2001 Sep-Oct; 8(5):368-71.
    View PubMed
  194. Stewart EA. Uterine fibroids. Lancet. 2001 Jan 27; 357(9252):293-8.
    View PubMed
  195. Yanushpolsky EH, Ginsburg ES, Fox JH, Stewart EA. Transcervical placement of a Malecot catheter after hysteroscopic evaluation provides for easier entry into the endometrial cavity for women with histories of difficult intrauterine inseminations and/or embryo transfers: a prospective case series. Fertil Steril. 2000 Feb; 73(2):402-5.
  196. Stewart EA, Sahakian M, Rhoades A, Van Voorhis BJ, Nowak RA. Messenger ribonucleic acid for the gonadal luteinizing hormone/human chorionic gonadotropin receptor is not present in human endometrium. Fertil Steril. 1999 Feb; 71(2):368-72.
    View PubMed
  197. Austin DJ, Nowak RA, Stewart EA. Onapristone suppresses prolactin production in explant cultures of leiomyoma. Gynecol Obstet Invest. 1999; 47(4):268-71.
    View PubMed
  198. Nowak RA, Mora S, Diehl T, Rhoades AR, Stewart EA. Prolactin is an autocrine or paracrine growth factor for human myometrial and leiomyoma cells. Gynecol Obstet Invest. 1999; 48(2):127-32.
    View PubMed
  199. Stewart EA, Nowak RA. New concepts in the treatment of uterine leiomyomas. Obstet Gynecol. 1998 Oct; 92(4 Pt 1):624-7.
    View PubMed
  200. Lee BS, Stewart EA, Sahakian M, Nowak RA. Interferon-alpha is a potent inhibitor of basic fibroblast growth factor-stimulated cell proliferation in human uterine cells. Am J Reprod Immunol. 1998 Jul; 40(1):19-25.
    View PubMed
  201. Stewart EA, Rhoades AR, Nowak RA. Leuprolide acetate-treated leiomyomas retain their relative overexpression of collagen type I and collagen type III messenger ribonucleic acid. J Soc Gynecol Investig. 1998 Jan-Feb; 5(1):44-7.
    View PubMed
  202. Anania CA, Stewart EA, Quade BJ, Hill JA, Nowak RA. Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding. Mol Hum Reprod. 1997 Aug; 3(8):685-91.
    View PubMed
  203. Stewart EA, Nowak RA. Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era. Hum Reprod Update. 1996 Jul-Aug; 2(4):295-306.
    View PubMed
  204. Stewart EA, Austin DJ, Jain P, Penglase MD, Nowak RA. RU486 suppresses prolactin production in explant cultures of leiomyoma and myometrium. Fertil Steril. 1996 Jun; 65(6):1119-24.
    View PubMed
  205. Stewart EA, Jain P, Penglase MD, Friedman AJ, Nowak RA. The myometrium of postmenopausal women produces prolactin in response to human chorionic gonadotropin and alpha-subunit in vitro. Fertil Steril. 1995 Nov; 64(5):972-6.
    View PubMed
  206. Stewart EA, Floor AE, Jain P, Nowak RA. Increased expression of messenger RNA for collagen type I, collagen type III, and fibronectin in myometrium of pregnancy. Obstet Gynecol. 1995 Sep; 86(3):417-22.
    View PubMed
  207. Stewart EA, Friedman AJ, Peck K, Nowak RA. Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle. J Clin Endocrinol Metab. 1994 Sep; 79(3):900-6.
    View PubMed
  208. Stewart EA, Rein MS, Friedman AJ, Zuchowski L, Nowak RA. Glycoprotein hormones and their common alpha-subunit stimulate prolactin production by explant cultures of human leiomyoma and myometrium. Am J Obstet Gynecol. 1994 Feb; 170(2):677-83.
    View PubMed
  209. Stewart EA, Jackson KV, Friedman AJ, Rein MS, Fox JH, Hornstein MD. The effect of baseline complex ovarian cysts on in vitro fertilization outcome. Fertil Steril. 1992 Jun; 57(6):1274-8.
    View PubMed
  210. Stewart EA, Friedman AJ. Steroidal treatment of myomas: preoperative and long-term medical therapy. Semin Reprod Endocrinol.1992;10 (4):344-57.
  211. Stewart EA, Liau AS, Friedman AJ. Operative laparoscopy followed by colpotomy for resecting a colonic leiomyosarcoma. A case report. J Reprod Med. 1991 Dec; 36(12):883-4.
    View PubMed
  212. Friedman A, Haas S, Kredentser J, Stewart E, Schiff I. A controlled trial of intrauterine insemination for cervical factor and male factor: a preliminary report. Int J Fertil. 1989 May-Jun; 34(3):199-203.
    View PubMed
PST-20224429